Skip Navigation



Bioinformatics Advance Access published online on June 18, 2008

Bioinformatics, doi:10.1093/bioinformatics/btn316
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
24/16/1812    most recent
btn316v1
Right arrow Comments: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Oh, J. H.
Right arrow Articles by Gao, J. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oh, J. H.
Right arrow Articles by Gao, J. X.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2008). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Biomarker selection and sample prediction for multi-category disease on MALDI-TOF data

Jung Hun Oh 1, Young Bun Kim 1, Prem Gurnani 2, Kevin Rosenblatt 3 and Jean X. Gao 1,*

1Department of Computer Science and Engineering, The University of Texas, Arlington, TX 76019, USA, 2PerkinElmer Life & Analytical Sciences, Waleham, MA 02451, USA, and 3Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA

*To whom correspondence should be addressed. Prof. Jean X. Gao, E-mail: gao{at}uta.edu


   Abstract

Motivation: Diseases normally progress in several stages. Therefore, there exist biomarkers corresponding to each stage. To deal with such a multi-category problem including sample stage prediction and biomarker selection, we propose methods for classification and feature selection. The proposed classification method is based on two schemes: error-correcting output coding (ECOC) and pairwise coupling (PWC). The final decision for a test sample prediction is the integration of these two schemes. The biomarker pattern for distinguishing each disease category from another one is achieved by the development of an Extended Markov Blanket (EMB) feature selection method.

Results: In the study, a liver cancer MALDI-TOF (matrix-assisted laser desorption/ionization time-of-flight) mass spectrometry (MS) data set was used, which consists of hepatocellular carcinoma (HCC), cirrhosis, and healthy spectra. Peak patterns were discovered for distinguishing pairwise categories among the three classes. Importance and reliability of individual peaks were presented by the measurements of certain weight values and frequencies. The classification capability of the proposed approach was compared with classical ECOC, random forest, Naive Bayes, and J48 methods.

Availability: Supplemental materials are available at http://visionlab.uta.edu/biomarker/bioinfo.htm

Contact: gao{at}uta.edu

Associate Editor: Dr. Jonathan Wren


Received on April 4, 2008; revised on May 25, 2008; accepted on June 12, 2008

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Acta Biochim Biophys SinHome page
Y. Pei, T. Zhang, V. Renault, and X. Zhang
An overview of hepatocellular carcinoma study by omics-based methods
Acta Biochim Biophys Sin, January 1, 2009; 41(1): 1 - 15.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.